UNSPSC 85722044: Removal of autologous tissue substitute from right metatarsal-tarsal joint, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to removal of autologous tissue substitute from right metatarsal-tarsal joint, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SPK37Z

UNSPSC 85722044 Removal of autologous tissue substitute from right metatarsal-tarsal joint, percutaneous approach is a Commodity code that does not reflect the work actually being solicited by state and local governments under recent postings. The code's clinical descriptor refers to a specific orthopedic surgical procedure, but recent opportunities tagged to this code do not involve surgical implant removal, tissue substitutes, or orthopedic surgical services. Instead, the opportunities span occupational medical surveillance, disability medical evaluations, pharmacy benefit management, temporary health professional staffing, and hospital-based emergency and specialty care services — none of which align with the code's stated scope. This represents a significant mismatch between the code taxonomy and actual procurement activity, indicating that either the code has been misapplied to these opportunities or the code does not capture active state and local procurement in this category.

The issuing bodies include a city retirement office (City of Phoenix), a state transportation department (Washington State Department of Transportation), a county health system (Santa Clara County Health System), a county juvenile probation department (Harris County), and county government procurement offices (Collier County, City of Long Beach). Recent opportunities show response dates ranging from September 25, 2026 through October 16, 2026, with one earlier Collier County pharmacy solicitation already past its April 9, 2026 deadline. Geographic activity is scattered across Arizona, Washington, California, Florida, and Texas with no concentration in any region. Given the absence of recent opportunities that actually involve orthopedic tissue-substitute surgical removal or related implant services, this code shows little relevant procurement signal for firms pursuing work in its nominal scope.